"Acetazolamide" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
One of the CARBONIC ANHYDRASE INHIBITORS that is sometimes effective against absence seizures. It is sometimes useful also as an adjunct in the treatment of tonic-clonic, myoclonic, and atonic seizures, particularly in women whose seizures occur or are exacerbated at specific times in the menstrual cycle. However, its usefulness is transient often because of rapid development of tolerance. Its antiepileptic effect may be due to its inhibitory effect on brain carbonic anhydrase, which leads to an increased transneuronal chloride gradient, increased chloride current, and increased inhibition. (From Smith and Reynard, Textbook of Pharmacology, 1991, p337)
| Descriptor ID |
D000086
|
| MeSH Number(s) |
D02.886.675.867.060 D03.383.129.708.867.060
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Acetazolamide".
Below are MeSH descriptors whose meaning is more specific than "Acetazolamide".
This graph shows the total number of publications written about "Acetazolamide" by people in this website by year, and whether "Acetazolamide" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1999 | 0 | 1 | 1 |
| 2000 | 1 | 0 | 1 |
| 2002 | 0 | 1 | 1 |
| 2003 | 0 | 1 | 1 |
| 2007 | 1 | 0 | 1 |
| 2009 | 0 | 1 | 1 |
| 2010 | 0 | 1 | 1 |
| 2012 | 0 | 1 | 1 |
| 2013 | 1 | 0 | 1 |
| 2015 | 0 | 1 | 1 |
| 2016 | 0 | 1 | 1 |
| 2019 | 1 | 0 | 1 |
| 2020 | 1 | 1 | 2 |
| 2021 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Acetazolamide" by people in Profiles.
-
Vaysbrot EE, Bannuru RR, Christopher MC, Osani MC, Halperin JJ. Papilledema Secondary to Neurologic Lyme Borreliosis: A Meta-Case Series. J Neuroophthalmol. 2021 12 01; 41(4):e498-e508.
-
Hampson AJ, Schroeder JR, Ellefsen KN, Yammine L, Epstein DH, Preston KL, Huestis MA, Verrico CD. Subtherapeutic Acetazolamide Doses as a Noninvasive Method for Assessing Medication Adherence. Clin Pharmacol Ther. 2020 12; 108(6):1203-1212.
-
Daou BJ, Sweid A, Weinberg JH, Starke RM, Sergott RC, Doermann AS, Hauge J, Zanaty M, Chalouhi N, Gooch R, Herial N, Zarzour H, Jabbour P, Rosenwasser RH, Tjoumakaris S. Effect of Shunting on Visual Outcomes and Headache in Patients with Idiopathic Intracranial Hypertension. World Neurosurg. 2020 10; 142:e73-e80.
-
Guimaraes TAC, Capasso JE, Levin AV. Paradoxical response to carbonic anhydrase inhibitors in patients with intraretinal cystoid spaces. Ophthalmic Genet. 2019 06; 40(3):213-218.
-
Lingao MD, Ganesh A, Karthikeyan AS, Al Zuhaibi S, Al-Hosni A, Al Khayat A, Capasso J, Trumler AA, Stroh E, Al Shekaili H, Cater JR, Levin AV. Macular cystoid spaces in patients with retinal dystrophy. Ophthalmic Genet. 2016 12; 37(4):377-383.
-
Cordovez JA, Traboulsi EI, Capasso JE, Sadagopan KA, Ganesh A, Rychwalski PJ, Neely KA, Brodie SE, Levin AV. Retinal Dystrophy with Intraretinal Cystoid Spaces Associated with Mutations in the Crumbs Homologue (CRB1) Gene. Ophthalmic Genet. 2015; 36(3):257-64.
-
Krejza J, Rudzinski W, Arkuszewski M, Onuoha O, Melhem ER. Cerebrovascular reactivity across the menstrual cycle in young healthy women. Neuroradiol J. 2013 Aug; 26(4):413-9.
-
Firwana BM, Hasan R, Hasan N, Alahdab F, Alnahhas I, Hasan S, Varon J. Tumor lysis syndrome: a systematic review of case series and case reports. Postgrad Med. 2012 Mar; 124(2):92-101.
-
Mouzaki M, Nichter C, Qureshi M, Rountree B, Furuya KN. Idiopathic intracranial hypertension in two patients with Alagille syndrome. J Child Neurol. 2010 Aug; 25(8):1006-8.
-
de Barros DS, Navarro JB, Mantravadi AV, Siam GA, Gheith ME, Tittler EH, Baez KA, Martinez SM, Spaeth GL. The early flat anterior chamber after trabeculectomy: a randomized, prospective study of 3 methods of management. J Glaucoma. 2009 Jan; 18(1):13-20.